To assess these hypotheses we performed a proof-of-concept study using a putative synthetic PPARγ agonist with the objective to test if activation of PPARγ prior to and during induced subclinical mastitis (1) improves the response to mastitis and (2) affects milk fat synthesis in dairy goats. The gene discussed is PPARG; the disease is mastitis.